Zogenix Raises $60M
San Diego-based Zogenix has raised $60M in a Series A financing, the firm announced this morning. The company received funding from Clarus Ventures and Domain Associates, along with additional investors BA Venture Partners, Thomas, McNerney & Partners, and Life Science Angels. The funding will be used in an acquisition of migraine treatment technology from Hayward, California-based Aradigm Corporation. Zogenix has purchased Aradigm's Intraject subcutaneous delivery technology to Zogenix. The firm plans to develop and commercialize the product.
posted on Monday, August 28, 2006 (Link to more information)
Related companies:
Zogenix
Related stories:
> Zogenix Gets $18M In Debt
> Zogenix Calls Off IPO
> Zogenix Plans Follow-On Offering
> Zogenix Files For IPO
> Zogenix Gets $10M Loan Facility
socalTECH.com Home